SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Direxion Shares ETF Trust - Direxion Daily S&P Biotech Bull 3X ETF

Direxion Daily S&P Biotech Bull 3X Shares

A rebound in biotech stocks is driving LABU higher, with traders tracking the sectors move through XBI and positioning around upcoming inflation data that could affect rate-sensitive biotech shares. The community is split between expecting the bounce to continue and cautioning that LABUs 3x leverage can magnify pullbacks.

Berkshire Hathaway, Inc. is a holding company, which engages in the provision of property and casualty insurance and reinsurance, utilities and energy, freight rail transportation, finance, manufacturing, and retailing services. It operates through the following segments: Insurance, Burlington Northern Santa Fe, LLC (BNSF), Berkshire Hathaway Energy (BHE), Pilot Travel Centers (PTC), Manufacturing, McLane, and Service and Retailing. The Insurance segment includes the underwriting of GEICO, Berkshire Hathaway Primary Group, and Berkshire Hathaway Reinsurance Group. The BNSF segment involves the operation of railroad systems. The BHE segment focuses on regulated electric and gas utility, power generation and distribution, and real estate brokerage activities. The PTC segment consists of managing travel centers and marketing of wholesale fuel. The Manufacturing segment refers to industrial, consumer and building products, home building, and related financial services. The McLane segment covers the wholesale distribution of groceries and non-food items. The Service and Retailing segment relates to the provision of shared aircraft ownership programs, aviation pilot training, electronic components distribution, retailing businesses, automobile dealerships and trailer, and furniture leasing services. The company was founded by Oliver Chace in 1839 and is headquartered in Omaha, NE.

Berkshire Hathaway Inc. - Ordinary Shares - Class B

Berkshires quarterly results and stepped-up share repurchases are driving discussion: some traders view the buybacks as a vote of confidence from Greg Abel, while others focus on weaker insurance performance and question whether repurchases can continue.

Stellar (XLM) is a cryptocurrency launched in 2014. Stellar has a current supply of 50,001,786,837.39707 with 35,366,684,616.305855 in circulation. The last known price of Stellar is 0.15346137 USD and is down -1.11 over the last 24 hours. It is currently trading on 848 active market(s) with $109,670,947.94 traded over the last 24 hours. More information can be found at https://www.stellar.org.

Stellar Lumens

XLMs persistent selloff and underperformance dominate discussion, with traders warning of further losses while others treat the decline as a buying opportunity. Bulls point to Stellars tokenization and institutional-adoption prospects, including DTCC-related plans, but skeptics argue that partnerships have not translated into token demand and question the tokenomics.

Accenture is a global professional services company that helps the world’s businesses, governments and other organizations build their digital core, optimize their operations, accelerate revenue growth and enhance citizen services, creating tangible value at speed and scale. The firm combines technology and leadership in cloud, data and AI with industry experience, functional expertise and global delivery capability. Its services include Strategy & Consulting, Technology, Operations, Industry X, and Song. It operates through the following geographical segments: North America, EMEA, and Growth Markets. The company was founded in 1989 and is headquartered in Dublin, Ireland.

Accenture plc - Ordinary Shares - Class A

Accenture is drawing attention as traders question whether enterprise AI projects will translate into sustained consulting revenue or instead reduce billable work and pressure margins. The debate is playing out against a sharp rally and technical resistance, with bearish traders watching for a pullback and bulls pointing to insider buying and continued demand for AI implementation.

Mineralys Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on developing medicines to target diseases driven by abnormally elevated aldosterone. Its clinical-stage product candidate, lorundrostat, is a proprietary, orally administered, highly selective aldosterone synthase inhibitor that are initially developing for the treatment of cardiorenal conditions affected by abnormally elevated aldosterone, including hypertension and chronic kidney disease. The company was founded by Brian Taylor Slingsby on May 31, 2019 and is headquartered in Radnor, PA.

Mineralys Therapeutics Inc

Attention centers on long-term lorundrostat data reporting that blood-pressure benefits persisted for two years after treatment ended, alongside the upcoming FDA decision on the hypertension drug. Traders view the durability findings as encouraging but remain divided amid the stocks weakness and the binary regulatory catalyst.

Roku, Inc. engages in the provision of a streaming platform for television. It operates through the following segments: Platform and Devices. The Platform segment includes the sale of digital advertising and distribution of streaming services. The Devices segment is involved in the sale of streaming players, Roku-made televisions, smart home products and services, audio products, and related accessories. The company was founded by Anthony J. Wood in October 2002 and is headquartered in San Jose, CA.

Roku Inc - Ordinary Shares - Class A

Roku Inc

Foxs acquisition of Roku has closed, ending ROKUs run as a standalone Nasdaq-listed company and shifting holders into the deals cash-and-Fox-stock consideration. The community is marking the end of the ticker with a mix of congratulations and disappointment that the sale capped Rokus potential, while some traders are also discussing bullish call activity.

J.P. Morgan Exchange-Traded Fund Trust - JPMorgan Nasdaq Equity Premium Income ETF

JPMorgan Nasdaq Equity Premium Income ETF

A Nasdaq and technology-sector selloff is weighing on JEPQ, prompting traders to compare its decline with the broader tech pullback. Many are buying the dip for monthly income, while others question whether distributions offset the funds price weakness and limited upside from its covered-call strategy.

Corvus Pharmaceuticals, Inc. engages in the development of product candidates for the treatment of cancer and immune-mediated and inflammatory diseases. Its product candidates include soquelitinib, an ITK inhibitor, ciforadenant, an adenosine A2A receptor antagonist, and mupadolimab, a B cell-activating anti-CD73 antibody. The company was founded by Richard A. Miller, Peter A. Thompson, Joseph J. Buggy, and Erik Verner on January 27, 2014 and is headquartered in South San Francisco, CA.

Corvus Pharmaceuticals Inc

Corvus is drawing attention for the potential of its ITK inhibitor soquelitinib across several clinical indications, with traders watching for trial updates and possible partnerships. Optimists point to the science and reported institutional or insider buying, while skeptics focus on delayed data, the long path to revenue, and persistent short interest.

Invesco DB US Dollar Index Bullish Fund - Invesco DB US Dollar Index Bullish Fund

Invesco DB US Dollar Index Bullish Fund

A rebound in the U.S. dollar, with traders watching payrolls data and the Fed rate outlook, is the main focus for UUP. Some see continued dollar strength as a headwind for stocks and precious metals, while others question whether the move will last.

Citigroup, Inc. is a holding company, which engages in the provision of financial products and services. It operates through the following segments: Services, Markets, Banking, Wealth, U.S. Personal Banking (USPB), and All Other. The Services segment includes Treasury and Trade Solutions (TTS) which provides an integrated suite of tailored cash management, trade, and working capital solutions to multinational corporations, financial institutions and public sector organizations, and Securities Services, which offers cross-border support for clients, providing on-the-ground local market expertise, post-trade technologies, customized data solutions, and a wide range of securities services solutions that can be tailored to meet client needs. The Markets segment provides corporate, institutional, and public sector clients around the world with a full range of sales and trading services across equities, foreign exchange, rates, spread products, and commodities. The Banking segment offers Investment Banking and Corporate Lending services. The Wealth segment includes Private Bank, Wealth at Work, and Citigold and provides financial services to a range of client segments through banking, lending, mortgages, investment, custody, and trust product offerings. The USPB segment includes Branded Cards and Retail Services, which have proprietary card portfolios and co-branded card portfolios within Branded Cards, and co-brand and private label relationships within Retail Services. The All Other segment consists of activities not assigned to the reportable operating segments, including certain unallocated costs of global functions, other corporate expenses, and net treasury results. The company was founded in 1812 and is headquartered in New York, NY.

Citigroup Inc

Citigroups quarterly earnings dominate discussion: the bank beat expectations, yet shares fell, leaving traders debating whether higher credit-loss provisions and card-business pressure outweighed stronger results. Some view the selloff as an opportunity, while others remain concerned about costs and credit quality.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Michael Burry ‘Docked LULU’ For Near-Term ‘Uncertainty’ — Believes Lululemon ‘Will Come Back’

Equity

Michael Burry is confident Lululemon will recover despite the stock’s 48% crash this year. 


NKE Stock Ticks Higher Overnight: Nike Unveils 'Vegam Run' For The World's Largest Population Amid China Sales Slump 

Nike is targeting growing running demand in India as declining China sales and weak revenue continue to pressure.  


DECK Stock Tumbles Overnight: HOKA Maker Sees ‘Measured Growth’ Over Next 2 Quarters As Consumers Seek Discounts  

Deckers is taking a more cautious approach to growth as tighter consumer budgets and rising footwear discounts challenge its U.S. business.

NKE Stock Wrapped Its Best Week In 3 Months: Analyst Says Nike Will Recover From ‘Lackluster Product Development,’ Shares Undervalued 

Morningstar expects innovation, marketing, retail partnerships, and $2.5 billion in cost savings to support a long-term recovery. 


VSXY Stock Rises Overnight: Victoria’s Secret Taps Kylie Jenner’s Star Power To Spruce Up Fashion Show Buzz 

Victoria’s Secret returned to Los Angeles with a star-studded fashion show.


LULU Stock Heads For Second Week Of Decline: Lululemon Overhauls Leadership To Reignite Growth 

New product and operations leaders aim to boost Lululemon’s innovation and strengthen its connection with customers. 


‘The Big Short’ Investor Michael Burry Justifies Lululemon Tax-Loss Sale: ‘I Am Not Throwing In The Towel’ 

Michael Burry sold Lululemon to harvest tax losses and bought Deckers as a temporary proxy. 


NKE Stock Heads For Its Worst Year Ever: Nike’s 45% Plunge Tests Investor Patience As China And Core Brands Weaken

Nike’s weak China sales, struggling brands, and analyst downgrades are raising doubts about the company’s turnaround. 

NKE Stock Heads For A Weekly Loss: Morningstar Says Nike's Fresh Cost Cuts Signal A Longer Road To Recovery 

Nike stock slides as Morningstar flags a prolonged turnaround, citing weak sales, Greater China challenges, and restructuring costs.


NKE Stock Ticks Higher Overnight: Retail Stays Bullish On Nike Ahead of Q1 Earnings – 'Time To Reinvest' 

Nike faces a major earnings test as shares plunge 44% year-to-date, and short interest reaches 87 million shares. 


Corgi ETF Trust I. - Corgi Lifestyle Brands ETF

Neutral Sentiment

<ul class="summary-bullets"><li>Michael Burry said he lowered his Lululemon valuation to reflect near-term growth uncertainty.</li><li>He remains optimistic about Lululemon’s long-term recovery.&nbsp;</li><li>Burry sold Lululemon shares to claim a tax benefit and temporarily switched to Deckers.&nbsp;</li></ul><p>“The Big Short” fame Michael Burry said he lowered his valuation estimate for Lululemon Athletica (LULU) due to near-term growth uncertainty but remains confident the stock will recover. The investor said he does not want to assume overly optimistic growth expectations for the beaten-down athletic apparel maker.&nbsp;&nbsp;</p><p><a href="https://stocktwits.com/symbol/LULU">Lululemon Athletica stock</a> ticked 0.02% higher overnight, ahead of Tuesday. The stock has plunged over 48% so far this year and is on track for its worst year ever.&nbsp;</p><h2 class="st-heading-2">Burry Takes Cautious View On Lululemon's Near-Term Growth&nbsp;</h2><p>In his Substack chat, Michael Burry, the investor known for predicting the 2008 financial crisis, said his revised assessment on Lululemon reflects a cautious outlook rather than a loss of confidence.</p><p>Responding to a subscriber's question about why he prefers Lululemon over Birkenstock (BIRK), despite the latter appearing to have a stronger competitive advantage and a cheaper valuation, Burry said he lowered Lululemon's IV15 assessment to account for uncertainty around near-term performance. Burry&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://substack.com/chat/group/84c5be97-fe11-4d8d-ac18-03a24c19e5a9/post/2e54abb1-575d-4626-915b-736ed45b202e/reply/bed674f9-a0a4-4b1f-b31c-c948f5bfc5e2">said</a> he lowered Lululemon's IV15 assessment to reflect uncertainty around its near-term performance.</p><p>"I docked LULU a bit on the IV15 due to uncertainty but I think it will come back. I just don’t want to build the IV15 around an optimistic near term as far as growth, so I adjusted it."&nbsp;</p><p>IV15 is Michael Burry's way of estimating what a stock is worth today while targeting a 15% annual return. He uses this valuation method to find "Fat Pitches" — stocks that trade well below what he believes they could be worth over the long term as their businesses grow.</p><h2 class="st-heading-2">Burry’s Temporary Switch to Deckers From Lululemon</h2><p>Earlier this month, Burry&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/the-big-short-investor-michael-burry-justifies-lululemon-tax-loss-sale-i-am-not-throwing-in-the-towel/cZDstsERBk4">sold</a> his Lululemon shares to book a tax loss and temporarily bought Deckers Outdoor (DECK) instead. He said he plans to buy Lululemon again after 30 days, once the IRS wash-sale restriction period ends.&nbsp;</p><p>Burry made the switch after Lululemon shares dropped to $91.28, their lowest level in more than eight years, amid weak sales and a reduced full-year outlook. He said Deckers would help him maintain similar market exposure during the waiting period because he expects both companies to benefit from the same recovery trends.&nbsp;</p><p>Lululemon shares have surged nearly 1,000% between 2017 and 2023 but have plunged 78% from their 2023 peak. The stock has continued to fall even after entering bear-market territory and becoming technically oversold.&nbsp;</p><h2 class="st-heading-2">LULU Stock: Retail View&nbsp;</h2><p>On Stocktwits, retail sentiment around the stock slipped to ‘bearish’ from ‘neutral’.&nbsp;</p><p>LULU stock has crashed 48% year-to-date.&nbsp;</p><p>Read Next:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/bill-ackman-pershing-square-wall-street-penalizing-hyperscalers-build-out-costs-ignoring-growth-potential/cNGQt6GR955">Bill Ackman's Pershing Square Says Wall Street Is 'Penalizing Hyperscalers' For Build-Out Costs, Ignoring Growth Potential</a></p><p><i>For updates and corrections, email newsroom[at]stocktwits[dot]com.</i></p>

Michael Burry attends "The Big Short" New York premiere at Ziegfeld Theater on November 23, 2015 in New York City. 

“The Big Short” fame Michael Burry said he lowered his valuation estimate for Lululemon Athletica (LULU) due to near-term growth uncertainty but remains confident the stock will recover. The investor said he does not want to assume overly optimistic growt

Lululemon Athletica Inc

Up more than 1% 

Flat to up 1%

Flat to down 1%

Down more than 1%

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Current Price	$26.63
Prev Close	$27.10
Open	$26.63
Dividend Yield	N/A
50-Day Moving Average	$24.84
Beta	N/A
Avg. Volume	231.52
PE Ratio	N/A

52-Week High	$28.08
52-Week Low	$23.42
Market Capitalization	N/A
EPS (Annual)	N/A
Price to Book	N/A
Revenue Per Employee	N/A

Feed

News

Sentiment

Fundamentals

Info

STYL Fundamentals